Advancing the Development of Imsidolimab with AnaptysBio

2020-07-09

We are excited to share some good news! Congratulations AnaptysBio on the orphan drug designation of imsidolimab for the treatment of GPP! We are thrilled to manage this clinical trial and help advance the development of imsidolimab.

For more information on our services, visit https://innovaderm.com/full-service-dermatology-cro/

About Anaptys:

AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation.

Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

"Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience (...)” - An Inmagene Biopharmaceuticals Testimonial

Our remarkable team has received high praise from yet another satisfied customer! "Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration." Duong Nguyen, Head of Clinical Operations at Inmagene Biopharmaceuticals. “Innovaderm’s profound understanding of alopecia areata and their forward-thinking […]

Dr. Robert Bissonnette, EY Entrepreneur Of The Year® 2024 finalist

We are thrilled to announce that Dr. Robert Bissonnette, the visionary founder, and CEO of Innovaderm Research, has been shortlisted for the esteemed EY Entrepreneur Of The Year® 2024 award. Dr. Bissonnette is a world-renowned key opinion leader in psoriasis and atopic dermatitis. His entrepreneurial spirit, curiosity, creativity, and analytical thinking have led Innovaderm to […]

Innovaderm Will Be At RAD In Chicago!

Innovaderm’s Founder and CEO, Dr. Robert Bissonnette, will be showcasing dermatology excellence at the Revolutionizing Atopic Dermatitis’s (RAD) annual conference in Chicago! 🎤✨ 📅 On June 9th, 4:10 p.m. CT During the Mini-Symposium 1—Therapeutic updates in AD: what you need to know right now!, Dr. Bissonnette will be presenting the segment “Topical Therapy Revolution”. Do not miss this […]

Advancing the Development of Imsidolimab with AnaptysBio

Newsletter subscription resources

Other recent articles

"Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience (...)” - An Inmagene Biopharmaceuticals Testimonial

Dr. Robert Bissonnette, EY Entrepreneur Of The Year® 2024 finalist

Innovaderm Will Be At RAD In Chicago!